26407-02-3

Upstream product

• 104-10-9 2-(4'-aminophenyl)ethyl alcohol 

Downstream Products

• 227467-57-4 2'-chloro-4'-(2-hydroxyethyl)-2,2,2-trifluoroacetanilide 
• 344285-89-8 ethyl N-[2-chloro-4-[2-((RS)-tetrahydropyran-2-yloxy)ethyl]phenyl]-N-trifluoroacetylaminoacetate 
• 227467-81-4 ethyl N-[2-chloro-4-[2-[[(1S, 2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-N-methylaminoacetate 
• 227467-78-9 ethyl N-[2-chloro-4-[2-[[(1S, 2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]phenyl]aminoacetate 
• 227467-58-5 2'-chloro-4'-[2-((RS)-tetrahydropyran-2-yloxy)ethyl]-2,2,2-trifluoroacetanilide 
• 227467-60-9 ethyl N-[2-chloro-4-(2-hydroxyethyl)phenyl]-N-methylaminoacetate 
• 227467-59-6 ethyl N-[2-chloro-4-(2-hydroxyethyl)phenyl]aminoacetate 
• 227467-63-2 ethyl N-[4-(2-bromoethyl)-2-chlorophenyl]aminoacetate 
• 227467-64-3 ethyl N-[4-(2-bromoethyl)-2-chlorophenyl]-N-methylaminoacetate 

Relevant academic research and scientific papers

BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to Bicyclic Heterocycle Derivatives, compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of GPR119 in a patient.